I'm a MadMother and I support the Sheller, P.C. Citizen Petition

This is the comment I left in support of Stephen Sheller's petition to immediately Revoke the Pediatric Indication for Risperdal® all Generic Version of Risperidone, and Invega®:

Risperdal was illegally marketed almost from the time it was FDA approved. It was prescribed to my son in 1995 to treat behavior problems he had. His diagnoses were PTSD and Left Temporal Lobe Epilepsy. He had been beat up and locked in a closet while in State care when he was three years old. Instead of the recommended treatment, he was given Risperdal which caused many adverse effects including causing visual problems. He was no longer able to read without a great deal of difficulty, and was given an additional diagnosis of Oppositional Defiant Disorder. The drugs caused him to no longer like the same foods and caused him to crave high fat foods which caused him to gain weight. It never treated the behavioral problems it was prescribed for. Eventually, he ended up in the State's psychiatric facility for children and was used in drug trials without Informed Consent in spite of my vehement protests. The federally funded researcher repeatedly told me I had no say in what he was doing to my son. My son was disabled as a result of the "treatment" he received from a so called expert in childhood schizophrenia. The researcher excluded the Left Temporal Epilepsy by removing the diagnosis from my son's medical record. The treatment my son received from a NIMH funded researcher, Jon McClellan, broke State, Federal, and International Laws and left my son disabled. Neuroleptic drugs are teratogens, just like the drugs which are used to treat cancer are teratogens.  Drugs that cause so many adverse effects including disability and death should not be prescribed off label to children. The fact that prescribers are not required to report adverse events including fatalities means we are not even counting how many children are disabled like my son, or how many are killed as a direct result of taking Risperdal. The betrayal of trust is overwhelming. Please revoke the pediatric approval for Risperdal and help prevent countless childhood iatrogenic disabilities and fatalities.
Sheller, P.C. - Citizen Petition

Agency: FDA
Document ID: FDA-2012-P-0857-0001
Your Comment Tracking Number: 1jw-81yp-i8pq

Teenage Girl Dies Following HPV Vaccine

via Alliance for Human Research Protection:

Death Following HPV vaccine 

Monday, 12 November 2012
Another child casualty of a commercially-driven vaccination policy.

Dr. Lucija Tomjenovic, a post-doctoral biochemist at the University of British Columbia School of Medicine, presented an abstractat the International Conference on Pharmacovigilance and Clinical Trials held in Chicago (October, 2012). The abstract of a detailed scientific paper about to be published by the Open Access publication OMICS, describes the abnormal autoimmune response 14 days following vaccination with the quadrivalent human papillomavirus (HPV), which ultimately led to the death of a 15-year old girl.

In Spain, on October 9, 2012, Don Carlos Álvarez Dardet, Professor of Preventive Medicine and Public Health at the University of Alicante, and Dña Alicia Capilla Lanagrán, Vice President of the AAVP (the Association of those Affected by Papillomavirus Vaccines) held a press conference to explain the reasons behind requests by medical professionals urging a Moratorium on the use of HPV vaccines in Spain.
Indeed, in 2009, more than 10,000 health professionals and scientific associations signed a document entitled, “Reasons for a Moratorium on the use of HPV vaccines in Spain,” and submitted it to the Department of Health.

The AAVP posted their demand for removal of HPV vaccines and the creation of a compensation fund for vaccine injury victims. Their website: www.nogracias.eu
See Rough English translation of Spain’s demand.


Read the illuminating detailed chapter by Mark Blaxill and Dan Olmsted analyzing the faulty basis for approval of the HPV vaccine in Vaccine Epidemic.

Vera Sharav


Death after quadrivalent human papillomavirus (qHPV) vaccination: Causal or coincidental?
October 7, 2012

By Lucija Tomljenovic, University of British Columbia, Canada
Presented at the International Conference on Pharmacovigilance and Clinical Trials, 1-3 October 2012

Herein reported is the case of a 15-year-old female without a relevant medical history, who developed severe headaches, speech problems, dizziness, weakness, inability to walk, depressed consciousness, confusion, amnesia and vomiting, 14 days after receiving her first qHPV vaccine injection. After the second vaccine booster, her symptoms worsened and she expired 15 days later. Autopsy revealed cerebral oedema and cerebellar herniation indicative of a focally disrupted blood-brain barrier.

There was no evidence of an active brain infection. Immunohistochemistry (IHC) examination of the brainstem, hippocampus and the cerebellum showed prominent infiltration of T-lymphocytes and macrophages in all brain areas examined. Notably, marked activation of the complement membrane attack complex (MAC) was detected in the cerebellar Purkinje cells, hippocampal neurons and portions of the brainstem. This pattern of MAC activation in the absence of an active brain infection indicates an abnormal triggering of the immune response in which the immune attack is directed towards self-tissue. Elevation of the pro-inflammatory IL-1 cytokine and intense micro- and astrogliosis were also evident in the patient’s brain. Altogether these observations strongly indicate that the acute neuronal damage resulting in patient’s death was due to an aberrant/excessive autoimmune and inflammatory response triggered by the vaccinations she received. Both the timing of the onset of symptoms as well as their nature, are consistent with previous case reports where causality between vaccination and the ensuing brain damage and/or death, was either demonstrated or strongly suspected. It thus appears that in some cases vaccination may be the triggering factor of fatal autoimmune/neurological events and physicians should be aware of this association.



Biography:

Lucija Tomljenovic holds a Ph.D in biochemistry and is currently a senior postdoctoral fellow at the University of British Columbia School of Medicine. Her current work focuses on neuroimmuno-toxic impacts of vaccine constituents, particularly aluminum adjuvants. She has published 7 papers in the last 12 months on the topic of vaccine safety in high-impact journals (JAMA, Annals of Medicine, Journal of Internal Medicine) and has recently presented her research as the invited speaker at the 8th International Congress on Autoimmunity in Granada. Tomljenovic serves as a peer reviewer for Vaccine, Journal of Inorganic Biochemistry, Lupus and Surgical Neurology International.

OMICS Publishing Group is an Open Access publication model that enables the dissemination of research articles to the global community. Thus, all articles published under open access can be accessed by anyone.

see also: 

Gardasil Researcher Drops A Bombshell

If your child is 13 in Washington State he or she can be prescribed drugs without your knowledge or permission

Washington State has some very strange ideas on what a minor can and cannot consent to. How many parents are aware of the risk these Laws and current standard practices pose to their children?

Washington State Law on Providing Health Care to Minors
Your child can get an abortion, be prescribed psychiatric drugs that can potentially disable them; that have fatal risks. Your consent is not required; you won't even be notified so you can watch for adverse effects...

via Alliance for Human Research Protection (links disabled)

Antipsychotics pose "Ominous long-term health implications" for children_JAMA

Wednesday, 28 October 2009

Prominent psychotropic drug investigators acknowledge that the rapid onset of cardiometabolic risks" is "alarming." They recommend that consideration be given for lower-risk alternatives. A study published in the current issue of The Journal of the American Medical Association [1], confirms that children and adolescents who are prescribed second generation neuroleptics are put at high risk of severe harm: prominent psychotropic drug investigators acknowledge that the rapid onset of "cardiometabolic risks" is "alarming." They recommend that consideration be given for lower-risk alternatives. This government-sponsored study is the largest ever conducted on first-time users of neuroleptics (a.k.a. antipsychotics). It sought to document the association of second-generation neuroleptics (antipsychotics) with body composition and metabolic parameters in patients not previously exposed to antipsychotic drugs. The four drugs in the study—Zyprexa (olanzapine), Risperdal (risperidone) Seroquel (quetiapine) and Abilify (aripiprazole)—are the most popular antipsychotic medications. They are industry blockbusters, with combined sales of $12.7 billion last year. Two hundred and fifty seven young children and adolescents, aged 4 to 19, in the New York study added 8% to 15% to their weight after taking one of four neuroleptics for only 11 weeks. Will the indisputable evidence of “ominous long-term health implications” from use of antipsychotics prompt the FDA to ban their use in children??? read the entire article at ahrp.org here.

Evelyn Pringle in OpEd news in 2006:
"A recent USA Today sponsored review of the FDA database from 2000 to 2004 found at least 45 deaths in children under 18 with atypical antipsychotics listed as the "primary suspect," and 1,328 reports of other serious side effects, some life-threatening.

The FDA's adverse event reporting system is known to capture only between 1% to 10% of side effects and deaths, which means the true numbers are actually much higher.

Among the 45 deaths, discussed in the May 2, 2006, USA article, at least six were related to diabetes, and other causes ranged from heart and pulmonary problems to choking, liver failure and suicide.

An 8-year-old boy died of cardiac arrest. A 15-year-old boy died of an overdose and a 13-year-old girl experienced diabetic ketoacidosis, a deficiency of insulin. The youngest child was 4, with symptoms that indicated diabetes complications." read here.

AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY 
PRACTICE PARAMETER FOR THE ASSESSMENT AND TREATMENT OF 
CHILDREN AND ADOLESCENTS WITH SCHIZOPHRENIA
This parameter was developed by Jon McClellan, M.D., and John Werry, M.D. and the Work 
Group on Quality Issues: William Bernet, M.D., Chair, Valerie Arnold, M.D., Joseph 
Beitchman, M.D., R. Scott Benson, M.D., Oscar Bukstein, M.D., Joan Kinlan, M.D., Jon 
McClellan, M.D., David Rue, M.D., and Jon A. Shaw, M.D. AACAP Staff: Kristin Kroeger.  
"Tardive Dyskinesia:  Tardive dyskinesia  (TD) is an involuntary movement disorder 
usually consisting of athetoid or choreic movements in the oro-facial region, but may 
affect any part of the body (Ernst et al., 1998). TD is a major public health concern in 
the treatment of schizophrenia, with both clinical and medicolegal implications. TD is 
typically associated with the long-term  use of neuroleptics (Ernst et al., 1998).  
Withdrawal dyskinesia may occur with  either gradual or sudden cessation of 
neuroleptic agents.  As many as 50 percent of youth on neuroleptics may experience 
some form of tardive or withdrawal dyskinesia (Ernst et al., 1998, Kumra et al., 
1998).  Withdrawal dyskinesias almost always resolve over time, whereas tardive 
dyskinesia may persist even if the antipsychotic agent is discontinued. 
Because there is no specific treatment for tardive dyskinesia other than 
discontinuing the medication, strategies for prevention and early detection need to be 
followed (APA, 1997)."  Practice Parameters

via Psychiatric Times May 6, 2011:
CLINICAL & RESEARCH NEWS Brain Volume Shrinkage Parallels Rise in Antipsychotic Drug Dosage  Aaron Levin
A magnetic imaging study of people with schizophrenia indicates that their brain volume decreases with use of antipsychotic medication. But what does that mean?

Magnetic resonance imaging of the brains of patients with schizophrenia suggests that while treatment with an antipsychotic drug may alleviate symptoms, it may also contribute to reductions in brain volume.

“It is possible that, although antipsychotics relieve psychosis and its attendant suffering, these drugs may not arrest the pathophysiological processes underlying schizophrenia and may even aggravate progressive brain tissue volume reductions,” said Beng-Choon Ho, M.D., an associate professor of psychiatry at the University of Iowa Carver College of Medicine, and colleagues in the February Archives of General Psychiatry.

The reduction in brain volume in schizophrenia occurs not because brain cells die off but rather because dendrites shrink and dendritic spines shrink, causing shrinkage in the synaptic connections in the cortex, explained Jeffrey Lieberman, M.D., another schizophrenia researcher not affiliated with the Iowa study.(emphasis mine)

“That's why in people with schizophrenia, thinking becomes more stereotyped, routinized, and concrete,” said Lieberman, a professor and chair of the Department of Psychiatry at Columbia University College of Physicians and Surgeons and director of the New York State Psychiatric Institute.

“They don't have the elaborate richness of synaptic connections to allow for the cognitive and intellectual processes to occur,” he said in an interview with Psychiatric News. read here.

It is definitive: The drugs cause brain damage, among other physiological neurological damaging effects.  How many parents or children thirteen and over are told this fact?  I sure wasn't.  There has been ample evidence in the professional literature of the deleterious effects of these drugs for decades---however, the drug industry denied the iatrogenic illnesses and the deaths caused to clinical trial participants and in the general population in real world use of these drugs; and the FDA claims it has NO duty to inform the public, of these facts.  The deaths and disabilities caused to patients who take the drugs are "Trade Secrets" according to the FDA.